MicroRNA signatures and Foxp3(+) cell count correlate with relapse occurrence in follicular lymphoma

First line drug treatment of follicular lymphoma (FL) patients is followed by a highly variable disease-free time before relapse in about one third of patients. No molecular marker is able to predict efficiently the risk of relapse. We investigated the expression profile of microRNAs (miRNAs) by mic...

Descripción completa

Detalles Bibliográficos
Autores principales: Malpeli, Giorgio, Barbi, Stefano, Greco, Corinna, Zupo, Simonetta, Bertolaso, Anna, Scupoli, Maria Teresa, Krampera, Mauro, Kamga, Paul Takam, Croce, Carlo Maria, Scarpa, Aldo, Zamò, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929439/
https://www.ncbi.nlm.nih.gov/pubmed/29731996
http://dx.doi.org/10.18632/oncotarget.24987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929439/
https://www.ncbi.nlm.nih.gov/pubmed/29731996
http://dx.doi.org/10.18632/oncotarget.24987

Ejemplares similares